PUB - Publikationen an der Universität Bielefeld

Alle markieren

• [9]
  

  2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2987695

  Krug D, Vladimirova V, Untch M, Kühn T, Schneeweiss A, Denkert C, Ataseven B, Solbach C, Gerber B, Tesch H, Golatta M, Seiler S, Heil J, Nekljudova V, Holtschmidt J, Loibl S (2024)
  Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy.
  Breast 74.

  PUB | DOI | PubMed | Europe PMC
   
• [8]
  

  2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987540

  Herold N, Schmolling J, Ernst C, Ataseven B, Bluemcke B, Schoemig-Markiefka B, Heikaus S, Goehring U-J, Engel C, Lampe B, Rhiem K, Harter P, Hauke J, Schmutzler RK, Hahnen E (2024)
  Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer.
  In: Abstracts from the 56th European Society of Human Genetics (ESHG) Conference. European Journal of Human Genetics , 32. London: Nature: 548.

  PUB | WoS
   
• [7]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2979534

  Imterat M, Harter P, Rhiem K, Heitz F, Schneider S, Concin N, Moubarak M, Welz J, Vrentas V, Traut A, Hahnen E, Schmutzler R, du Bois A, Ataseven B (2023)
  Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients.
  Cancers 15(9): 2534.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [6]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2985382

  Slomovitz BM, Raaschou-Jensen N, Coleman RL, Gilbert L, Powell MA, Cibula D, Ghamande S, Zavallone L, Mendivil AA, Ataseven B, Black D, Wymenga M, Billingsley C, Willmott LJ, McCourt C, Podzielinski I, Doehring O, Garside J, Herzog TJ, Mirza MR (2023)
  PFS2 and adjustment of overall survival (OS) for subsequent anticancer therapy in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab plus chemotherapy or chemotherapy alone in the ENGOT-EN3-NSGO/GOG-3031/RUBY trial.
  In: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023. Annals of Oncology , 34. Amsterdam: Elsevier: S514-S515.

  PUB | DOI | WoS
   
• [5]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984317

  Marme F, Krieghoff-Henning E, Gerber B, Schmitt M, Zahm D-M, Bauerschlag D, Forstbauer H, Hildebrandt G, Ataseven B, Brodkorb T, Denkert C, Stachs A, Krug D, Heil J, Golatta M, Kühn T, Nekljudova V, Gaiser T, Schönmehl R, Brochhausen C, Loibl S, Reimer T, Brinker TJ (2023)
  Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images.
  European Journal of Cancer 195: 113390.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [4]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984002

  Imterat M, Gebers G, Heitz F, Schneider S, Ehmann S, Welz J, du Bois A, Traut A, Walz MK, Concin N, Harter P, Ataseven B (2023)
  Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study.
  Gynecologic Oncology 178: 96-101.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [3]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984318

  Bizzarri N, Imterat M, Fruscio R, Giannarelli D, Perrone AM, Mancari R, Traut A, Rosati A, du Bois A, Ferrari D, De Iaco P, Ergasti R, Ataseven B, Bianchi T, Di Stanislao M, Perri MT, Heitz F, Concin N, Fanfani F, Vizza E, Scambia G, Harter P, Fagotti A (2023)
  Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
  European Journal of Cancer 195: 113398.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [2]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2980959

  Herold N, Schmolling J, Ernst C, Ataseven B, Blümcke B, Schömig-Markiefka B, Heikaus S, Göhring U-J, Engel C, Lampe B, Rhiem K, Harter P, Hauke J, Schmutzler RK, Hahnen E (2023)
  Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer.
  Cancer Medicine .

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [1]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2979540

  Inci MG, Sehouli J, Schnura E, Lee M, Roll S, Reinhold T, Klews J, Kaufner L, Niggemann P, Groeben H, Toelkes J, Reisshauer A, Liebl M, Daehnert E, Zimmermann M, Knappe-Drzikova B, Rolker S, Nunier B, Algharably E, Pirmorady Sehouli A, Zwantleitner L, Krull A, Heitz F, Ataseven B, Chekerov R, Harter P, Schneider S (2023)
  The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design.
  International Journal of Gynecological Cancer : ijgc-2023-004531.

  PUB | DOI | WoS | PubMed | Europe PMC